We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
-10.21%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.49B
AUM Growth
+$329M
Cap. Flow
+$1.05B
Cap. Flow %
16.14%
Top 10 Hldgs %
17.7%
Holding
945
New
236
Increased
167
Reduced
92
Closed
153

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$112M
2
SWKS icon
Skyworks Solutions
SWKS
+$103M
3
STM icon
STMicroelectronics
STM
+$87.3M
4
ASML icon
ASML
ASML
+$71.6M
5
PANW icon
Palo Alto Networks
PANW
+$64.4M

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$169M
2
COO icon
Cooper Companies
COO
+$103M
3
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$102M
4
LRCX icon
Lam Research
LRCX
+$78.9M
5
KLAC icon
KLA
KLAC
+$76.8M

Sector Composition

Rank Sector Weight
1 Healthcare 34.94%
2 Technology 31.31%
3 Financials 8.29%
4 Industrials 7.52%
5 Communication Services 4.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
POSH
401
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
$2.4M 0.04%
+237,558
New +$2.74M
EXFY icon
402
Expensify
EXFY
$186M
$2.38M 0.04%
133,802
+15,806
+13% +$280K
VYGG
403
DELISTED
Vy Global Growth
VYGG
$2.33M 0.04%
+235,154
New +$2.33M
ARYD
404
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$2.32M 0.04%
236,880
+80,000
+51% +$784K
VERV
405
DELISTED
Verve Therapeutics
VERV
$2.29M 0.04%
150,000
– –
HRTX icon
406
Heron Therapeutics
HRTX
$96.8M
$2.28M 0.04%
818,162
+249,007
+44% +$1,000K
AMYT
407
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$2.28M 0.04%
326,312
-154,051
-32% -$1.2M
TNGX icon
408
Tango Therapeutics
TNGX
$4.78B
$2.27M 0.03%
500,095
– –
BNAI
409
Brand Engagement Network
BNAI
$91.7M
$2.21M 0.03%
22,500
– –
VEEA
410
Veea Inc
VEEA
$9.6M
$2.21M 0.03%
225,000
– –
AMPI
411
DELISTED
Advanced Merger Partners Inc
AMPI
$2.2M 0.03%
225,000
– –
DNZ
412
DELISTED
D and Z Media Acquisition Corp.
DNZ
$2.15M 0.03%
218,990
– –
KVSC
413
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
$2.13M 0.03%
+219,000
New +$2.14M
VRNA
414
DELISTED
Verona Pharma
VRNA
$2.1M 0.03%
+501,458
New +$2.14M
TYRA icon
415
Tyra Biosciences
TYRA
$1.93B
$2.07M 0.03%
289,172
+23,011
+9% +$183K
OPTU
416
Optimum Communications Inc
OPTU
$343M
$2.06M 0.03%
222,577
-351,759
-61% -$3.68M
AUTL
417
Autolus Therapeutics
AUTL
$519M
$2.06M 0.03%
726,114
-69,897
-9% -$213K
YTPG
418
DELISTED
TPG Pace Beneficial II Corp.
YTPG
$2.05M 0.03%
210,968
+13,979
+7% +$137K
MDRX
419
DELISTED
Veradigm Inc. Common Stock
MDRX
$2.02M 0.03%
136,521
+21,580
+19% +$403K
ERAS icon
420
Erasca
ERAS
$6.38B
$2.02M 0.03%
362,146
-96,003
-21% -$628K
ABOS icon
421
Acumen Pharmaceuticals
ABOS
$162M
$2M 0.03%
426,170
-75,066
-15% -$282K
ASBP
422
Aspire Biopharma
ASBP
$9.12M
$2M 0.03%
+167
New +$2M
HMA
423
DELISTED
Heartland Media Acquisition Corp.
HMA
$1.99M 0.03%
200,005
– –
BFAC
424
DELISTED
Battery Future Acquisition Corp.
BFAC
$1.99M 0.03%
200,000
– –
JGGC
425
DELISTED
Jaguar Global Growth Corporation I Class A Ordinary Shares
JGGC
$1.99M 0.03%
+200,000
New +$1.98M
15 16
17
18 19

Similar funds

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM

Woodline Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Woodline Partners held 945 positions worth $6.49B, up 5.3% from $6.16B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Woodline Partners deployed $1.05B of net new capital in Q2 2022, opening 236 new positions and adding to 167 existing holdings. Its largest new stake was Skyworks Solutions: 955,660 shares worth $88.5M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 39% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $169M trimmed.

  • Woodline Partners's largest Q2 2022 buy was Skyworks Solutions: 955,660 shares worth $88.5M.
  • Woodline Partners added most to Eli Lilly in Q2 2022, an estimated $112M increase.
  • Woodline Partners's biggest Q2 2022 reduction was Seagen Inc. Common Stock, cutting an estimated $169M.
  • Woodline Partners fully exited Cooper Companies in Q2 2022, selling an estimated $103M.
  • Woodline Partners's ten largest holdings make up 18% of its $6.49B portfolio in Q2 2022.
  • Woodline Partners opened 236 new positions and closed 153 in Q2 2022.
  • Woodline Partners's portfolio value rose 5.3% quarter-over-quarter to $6.49B.

Based on Woodline Partners's 13F filing for Q2 2022, filed 15 Aug 2022.